Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diabetes and associated disorders.
Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap.
Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Evaluating award-winning doctoral theses to reveal PhD research landscape: A case study of the Faculty of Medicine, University of Belgrade
Analysis of adherence to postpartum screening for early dysglycemia in women with previous gestational diabetes
Diabetic Myocardial Disorder. A Clinical Consensus Statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
Assessment of cardiovascular risk in patients with type 2 diabetes and albuminuric diabetic kidney disease phenotype
Changes in CD4+CD25HIGH T cells and TGFb1 levels in different stages of adult-onset type 1 diabetes
Type 1 diabetes: Prevention and screening in focus
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension.
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial.
Development of ALOHa-G Risk Score for Detecting Postpartum Dyslipidemia Among Normoglycemic Women with Previous Gestational Diabetes: Observational Cohort Study.
Prof. dr Đorđe Joannović, a corresponding member of Serbian Royal Academy, Dean, pathologist and the first Serbian oncologist, one of the world pioneers of the study of autoaggression, the founder and builder of the Institute of Pathology, the most tragic personality in the one-century-long history of the Faculty of Medicine: 151 years since birth and 90 years since death
Guideline Development for Medical Device Technology: Issues for Consideration.
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group.
Impact of comorbidities on the disability progression in multiple sclerosis.
Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells <i>in vitro</i>.
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Maternal and Fetal Outcomes among Pregnant Women with Diabetes.
Predictors of Clinical Inertia and Type 2 Diabetes: Assessment of Primary Care Physicians and Their Patients.
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure.
Trends of the Prevalence of Pre-gestational Diabetes in 2030 and 2050 in Belgrade Cohort.
Chronic Diabetic Complications: Current Challenges and Opportunities.
Matrix Metalloproteinase-2 (<i>MMP-2</i>) and-9 (<i>MMP-9</i>) Gene Variants and Microvascular Complications in Type 2 Diabetes Patients.